Resmed Inc at Goldman Sachs Global Healthcare Conference Transcript
Okay. I think in the interest time, let's make a start. So welcome again to day 1 of the Goldman Sachs Global Healthcare Conference. My name is Chris Cooper, I'm the Australian healthcare analyst. So today we've got Rob Douglas, the COO of ResMed. Thanks very much for joining us. I think Rob would just like to make a brief sort of introductory remark just to kind of set the scene.
Yes. Thanks, Chris. Thank you for having us here. I think you all know ResMed, we don't need to talk about sleep apnea and the fact that there is over 900 million untreated sleep apnea patients around the world and the fact that most of them don't know that they need their treatment. And so we've got a great opportunity still growing that core business and lots of our strategic moves are in -- around supporting that. Recently we've invested in also our COPD business. With our ventilators and our oxygen, we treat only a small proportion of COPD patients, but
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
